Recombinant multi-species EWS/EWSR1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine EWS/EWSR1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a multifunctional protein that is involved in various cellular processes, including gene expression, cell signaling, and RNA processing and transport. The protein includes an N-terminal transcriptional activation domain and a C-terminal RNA-binding domain. Chromosomal translocations between this gene and various genes encoding transcription factors result in the production of chimeric proteins that are involved in tumorigenesis. These chimeric proteins usually consist of the N-terminal transcriptional activation domain of this protein fused to the C-terminal DNA-binding domain of the transcription factor protein. Mutations in this gene, specifically a t(11;22)(q24;q12) translocation, are known to cause Ewing sarcoma as well as neuroectodermal and various other tumors. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 1 and 14. [provided by RefSeq, Jul 2009]
The Alternative Names of target: EWS,EWS oncogene,EWS-FLI1,EWSR1,Ewing sarcoma breakpoint region 1 protein,Ews,Ewsh,Ewsr1,RNA-binding protein EWS,bK984G1.4
Go
to EWS/EWSR1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP6449-Ag-1/ GM-Tg-hg-IP6449-Ag-2 | Human EWS/EWSR1 protein | Human |
| GM-Tg-rg-IP6449-Ag-1/ GM-Tg-rg-IP6449-Ag-2 | Rat EWS/EWSR1 protein | Rat |
| GM-Tg-mg-IP6449-Ag-1/ GM-Tg-mg-IP6449-Ag-2 | Mouse EWS/EWSR1 protein | Mouse |
| GM-Tg-cynog-IP6449-Ag-1/ GM-Tg-cynog-IP6449-Ag-2 | Cynomolgus/Rhesus macaque EWS/EWSR1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP6449-Ag-1/ GM-Tg-felg-IP6449-Ag-2 | Feline EWS/EWSR1 protein | Feline |
| GM-Tg-cang-IP6449-Ag-1/ GM-Tg-cang-IP6449-Ag-2 | Canine EWS/EWSR1 protein | Canine |
| GM-Tg-bovg-IP6449-Ag-1/ GM-Tg-bovg-IP6449-Ag-2 | Bovine EWS/EWSR1 protein | Bovine |
| GM-Tg-equg-IP6449-Ag-1/ GM-Tg-equg-IP6449-Ag-2 | Equine EWS/EWSR1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP6449-Ag-1/ GM-Tg-hg-IP6449-Ag-2;
GM-Tg-rg-IP6449-Ag-1/ GM-Tg-rg-IP6449-Ag-2;
GM-Tg-mg-IP6449-Ag-1/ GM-Tg-mg-IP6449-Ag-2; GM-Tg-cynog-IP6449-Ag-1/ GM-Tg-cynog-IP6449-Ag-2; GM-Tg-felg-IP6449-Ag-1/ GM-Tg-felg-IP6449-Ag-2; GM-Tg-cang-IP6449-Ag-1/ GM-Tg-cang-IP6449-Ag-2; GM-Tg-bovg-IP6449-Ag-1/ GM-Tg-bovg-IP6449-Ag-2; GM-Tg-equg-IP6449-Ag-1/ GM-Tg-equg-IP6449-Ag-2 |
| Products Name | EWS/EWSR1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | EWS/EWSR1 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine EWS/EWSR1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.